Clinical research: Cancer drug could treat Angelman syndrome
A cancer drug shows promise as a treatment for Angelman syndrome, according to a study published today in Nature.
By
Jessica Wright
21 December 2011 | 2 min read
This article is more than five years old.
Neuroscience—and science in general—is constantly evolving, so older articles may contain information or theories that have been reevaluated since their original publication date.
References:
- Huang H-S. et al. Nature Epub ahead of print (2011) Abstract
Explore more from The Transmitter
Rat neurons thrive in a mouse brain world, testing ‘nature versus nurture’
By
Angie Voyles Askham
17 May 2024 | 5 min read
It’s past time to stop using the Reading the Mind in the Eyes Test
By
Wendy C. Higgins, Robert M. Ross
16 May 2024 | 8 min read
Robots boost data consistency in rodent studies reliant on mechanical, optogenetic stimulation
By
Calli McMurray
15 May 2024 | 5 min read
Cite this article: